FMC Secures Regulatory Approval for Keenali Herbicide in Peru

17.04.25 15:38 Uhr

Werte in diesem Artikel
Aktien

35,90 EUR 1,37 EUR 3,97%

42,25 EUR 0,60 EUR 1,44%

Indizes

PKT PKT

1.912,8 PKT 15,2 PKT 0,80%

1.971,7 PKT 15,9 PKT 0,81%

22.242,5 PKT 177,9 PKT 0,81%

8.493,1 PKT 68,0 PKT 0,81%

1.758,2 PKT 13,4 PKT 0,77%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

201,3 PKT 0,5 PKT 0,25%

537,2 PKT 3,6 PKT 0,68%

11.640,0 PKT 95,4 PKT 0,83%

22.365,0 PKT -3,0 PKT -0,01%

22.296,1 PKT 225,2 PKT 1,02%

8.594,7 PKT 72,9 PKT 0,86%

16.982,9 PKT 143,0 PKT 0,85%

1.854,4 PKT -8,4 PKT -0,45%

FMC Corporation FMC has received regulatory approvals for its Keenali herbicide, powered by Dodhylex active, in Peru. With this approval, FMC’s first active ingredient and commercial product has received global registration for this breakthrough herbicide technology. Dodhylex active is the first and only herbicide to be classified as a Group 28 herbicide by the Herbicide Resistance Action Committee and the Weed Science Society of America.This marks a huge step in the field of agricultural innovation and scientific leadership, FMC noted. Continuous research on the use of Dodhylex is being conducted to discover new benefits in additional crops, including corn, soybean, sugarcane and sunflower to combat resistant weeds. With its proven performance in matters of crop safety and broad utility in Japonica and Indica rice, Keenali, with the new mode of action, is now set to offer Peruvian rice growers an effective solution for managing yield-reducing and resistant grass weeds, including key grass weeds. This approval has made 10% of more than 4.5 million planted hectares of rice across Latin America accessible to FMC. Keenali herbicide is anticipated to be commercially available in Peru in August. FMC awaits approval for Dodhylex active in other countries of Latin America. It has also submitted regulatory applications to India, Japan, Malaysia, South Korea, Taiwan and the United States for Keenali. FMC remains committed to innovation and a disciplined approach to advancing new molecules that help combat resistance and support food security for a growing population.FMC stock has lost 34.5% over the past year compared with the industry’s 10.6% decline.Image Source: Zacks Investment ResearchFMC’s Zacks Rank and Key PicksFMC currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the Basic Materials space are Carpenter Technology Corporation CRS, DRDGOLD Limited DRD and Idaho Strategic Resources, Inc. IDR. While CRS sports a Zacks Rank #1 (Strong Buy) at present, DRD and IDR carry a Zacks Rank #2 (Buy) each. You can see the complete list of today’s Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Carpenter Technology’s current fiscal-year earnings is pegged at $6.95 per share. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 15.7%. CRS’ shares have soared 116.9% in the past year.The Zacks Consensus Estimate for DRD’s current-year earnings is pegged at $1.06 per share, indicating a 29.3% year-over-year rise. Its shares have soared 102.4% in the past year.The Zacks Consensus Estimate for IDR’s 2025 earnings is pegged at 78 cents per share, indicating a rise of 16.4% from year-ago levels. IDR’s earnings beat the consensus estimate in three of the trailing four quarters while missing once, with the average surprise being roughly 77.5%. Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Carpenter Technology Corporation (CRS): Free Stock Analysis Report FMC Corporation (FMC): Free Stock Analysis Report DRDGOLD Limited (DRD): Free Stock Analysis Report Idaho Strategic Resources, Inc. (IDR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf FMC

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf FMC

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Wer­bung

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
23.04.2025Fresenius Medical Care (FMC) St NeutralUBS AG
23.04.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
22.04.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
22.04.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
22.04.2025Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
DatumRatingAnalyst
23.04.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
22.04.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
12.03.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
27.02.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
25.02.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
DatumRatingAnalyst
23.04.2025Fresenius Medical Care (FMC) St NeutralUBS AG
22.04.2025Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
22.04.2025Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
16.04.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
04.03.2025Fresenius Medical Care (FMC) St Market-PerformBernstein Research
DatumRatingAnalyst
17.04.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
21.03.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
04.03.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
26.02.2025Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
25.02.2025Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen